Advisor Group Holdings, Inc. Halozyme Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 21,079 shares of HALO stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,079

Previous 10,362 103.43%

Holding current value

$1.11 Million

Previous $542,000 122.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$51.3 - $64.42 $549,782 - $690,389	10,717 Added 103.43%	21,079 $1.21 Million
Q2 2024 Aug 13, 2024	BUY	$37.81 - $52.4 $63,104 - $87,455	1,669 Added 19.2%	10,362 $542,000
Q1 2024 May 10, 2024	SELL	$33.68 - $41.95 $158,430 - $197,332	-4,704 Reduced 35.11%	8,693 $353,000
Q4 2023 Feb 12, 2024	SELL	$33.32 - $42.1 $204,918 - $258,915	-6,150 Reduced 31.46%	13,397 $495,000
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $112,661 - $136,052	3,090 Added 18.78%	19,547 $746,000
Q2 2023 Aug 21, 2023	SELL	$30.28 - $38.74 $1.28 Million - $1.64 Million	-42,330 Reduced 72.01%	16,457 $593,000
Q2 2023 Aug 10, 2023	BUY	$30.28 - $38.74 $1.4 Million - $1.8 Million	46,338 Added 372.22%	58,787 $2.12 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $662,687 - $1.12 Million	-20,167 Reduced 61.83%	12,449 $475,000
Q4 2022 Feb 10, 2023	BUY	$40.06 - $59.44 $107,841 - $160,012	2,692 Added 9.0%	32,616 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $399,787 - $537,269	-10,376 Reduced 25.75%	29,924 $1.18 Million
Q2 2022 Aug 10, 2022	BUY	$37.35 - $48.3 $977,636 - $1.26 Million	26,175 Added 185.31%	40,300 $1.77 Million
Q1 2022 May 04, 2022	SELL	$31.97 - $41.06 $388,051 - $498,386	-12,138 Reduced 46.22%	14,125 $560,000
Q3 2021 Nov 05, 2021	BUY	$38.47 - $46.42 $484,760 - $584,938	12,601 Added 92.23%	26,263 $1.07 Million
Q2 2021 Aug 02, 2021	BUY	$38.84 - $51.31 $17,866 - $23,602	460 Added 3.48%	13,662 $623,000
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $1.85 Million - $2.41 Million	-46,923 Reduced 78.04%	13,202 $554,000
Q4 2020 Feb 10, 2021	BUY	$25.81 - $43.62 $1.27 Million - $2.15 Million	49,371 Added 459.09%	60,125 $2.57 Million
Q3 2020 Nov 12, 2020	SELL	$25.74 - $29.63 $46,409 - $53,422	-1,803 Reduced 14.36%	10,754 $285,000
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $70,817 - $116,837	4,358 Added 53.15%	12,557 $336,000
Q1 2020 May 18, 2020	BUY	$13.9 - $21.83 $113,966 - $178,984	8,199 New	8,199 $148,000

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Halozyme Therapeutics, Inc. Transaction History